Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are three key biomarkers used to classify breast cancer into four major molecular subtypes based on their expression levels [1]. This evidence concerns the gene PGR and breast carcinoma.